Table 2.
Characteristics of MDR P. aeruginosa strains with identified genes encoding aminoglycoside-modifying enzymes and Qnr-like proteins.
| Isolate | Specimen | Year of isolation | Genotype | MIC (μg/mL) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|||||||||||
| GM | AN | NC | CIP | IMP | MEM | FEP | CAZ | ||||
| PS-05 | urine | 2003 | aac(6′)-Ib+ant(2″)-Ia +qnrB | ≥ 256 | 64 | ≥ 256 | ≥ 32 | ≥ 32 | 16 | 48 | 4 |
| PS-07 | bronchial secretion | 2003 | qnrB | 8 | 64 | ≥ 256 | ≥ 32 | 16 | 2 | 32 | 2 |
| PS-09 | bronchoalveolar lavage | 2003 | aac(6′)-Ib | 16 | 128 | ≥ 256 | 4 | 2 | 2 | 16 | 4 |
| PS-10 | urine | 2004 | aac(6′)-Ib +qnrB | 32 | 128 | ≥ 256 | ≥ 32 | 16 | 2 | 4 | 2 |
| PS-12 | bronchial secretion | 2004 | ant(2″)-Ia | ≥ 256 | 64 | 32 | 4 | 2 | 16 | 16 | 2 |
| PS-15 | nasal swab | 2005 | aac(6′)-Ib | 64 | ≥ 256 | ≥ 256 | ≥ 32 | 16 | ≥ 32 | 32 | 32 |
| PS-16 | bronchial secretion | 2005 | ant(2″)-Ia | ≥ 256 | 64 | ≥ 256 | 1 | ≥ 32 | 16 | 16 | 8 |
| PS-17 | bronchoalveolar lavage | 2006 | aac(6′)-Ib +qnrB | ≥ 256 | ≥ 256 | ≥ 256 | ≥ 32 | ≥ 32 | ≥ 32 | 16 | 64 |
| PS-18 | blood | 2006 | ant(2″)-Ia | ≥ 256 | 128 | ≥ 256 | 8 | 16 | 1 | 48 | 32 |
| PS-19 | bronchial secretion | 2007 | ant(2″)-Ia | ≥ 256 | ≥ 256 | ≥ 256 | ≥ 32 | ≥ 32 | ≥ 32 | 4 | 1 |
| PS-21 | bronchial secretion | 2008 | ant(2″)-Ia | ≥ 256 | ≥ 256 | ≥ 256 | ≥ 32 | 16 | ≥ 32 | 32 | 64 |
| PS-22 | bronchial secretion | 2008 | aac(6′)-Ib+ant(2″)-Ia+aph(3″)-Ib | 16 | 128 | ≥ 256 | ≥ 32 | ≥ 32 | 16 | 48 | 16 |
| PS-23 | nasal swab | 2009 | aac(6′)Ib+ant(2″)-Ia | 128 | ≥ 256 | ≥ 256 | ≥ 32 | ≥ 32 | 2 | 32 | 2 |
| PS-25 | bronchial secretion | 2009 | ant(2″)-Ia+aph(3″)-Ib +qnrB | ≥ 256 | 128 | 8 | ≥ 32 | ≥ 32 | ≥ 32 | 32 | 1 |
GN = gentamicin; AN = amikacin; NC = netilmicin; CIP = ciprofloxacin; IMP = imipenem; MEM = meropenem; FEP = cefepime; CAZ = ceftazidime.